Koizume S, Takizawa S, Fujita K, Aida N, Yamashita S, Miyagi Y, Osaka H
Division of Neurology, Clinical Research Institute, Kanagawa Children's Medical Center, Mutsukawa 2-138-4, Minami-ku, Yokohama 232-8555, Japan.
Neuroscience. 2006 Sep 15;141(4):1861-9. doi: 10.1016/j.neuroscience.2006.05.067. Epub 2006 Jul 14.
Pelizaeus-Merzbacher disease (PMD) is a rare X-linked leukodystrophy caused by proteolipid protein 1 (PLP1) gene mutations. Previous studies indicated that proteolipid proteins (PLPs) with disease-associated mutations are misfolded and trapped in the endoplasmic reticulum (ER) during transportation to the cell surface, which eventually leads to oligodendrocyte cell death in PMD. Here we report a PMD patient with a very mild phenotype carrying a novel mutation (485G-->T) in exon 4 of the PLP1 gene that causes a Trp(162)Leu substitution in the protein. We also investigated intracellular trafficking of this mutant PLP in COS-7 cells. Transiently transfected mutant PLP(W162L) fused to an enhanced green fluorescent protein (EGFP) or a short peptide tag was not carried to the plasma membrane. However, in contrast to previous studies, this mutant PLP was not retained in the ER, indicating an escape of the newly translated protein from the quality control machinery. We also found that the mutant PLP accumulated in the nuclear envelope (NE) in a time-dependent manner. This mutant PLP, with its distribution outside the ER and a very mild phenotype, supports the idea that accumulation of misfolded mutant protein in the ER causes the severe phenotype of PMD.
佩利措伊斯-梅茨巴赫病(PMD)是一种罕见的X连锁性脑白质营养不良,由蛋白脂蛋白1(PLP1)基因突变引起。先前的研究表明,携带疾病相关突变的蛋白脂蛋白(PLPs)在转运至细胞表面的过程中发生错误折叠,并被困在内质网(ER)中,最终导致PMD中的少突胶质细胞死亡。在此,我们报告了一名具有非常轻微表型的PMD患者,其PLP1基因第4外显子携带一种新的突变(485G→T),该突变导致蛋白质中Trp(162)Leu替换。我们还研究了这种突变型PLP在COS-7细胞中的细胞内运输。瞬时转染的与增强型绿色荧光蛋白(EGFP)或短肽标签融合的突变型PLP(W162L)未被转运至质膜。然而,与先前的研究不同,这种突变型PLP并未保留在内质网中,这表明新翻译的蛋白质从质量控制机制中逃逸。我们还发现突变型PLP以时间依赖性方式积聚在核膜(NE)中。这种突变型PLP,其在内质网外的分布以及非常轻微的表型,支持了内质网中错误折叠的突变蛋白积聚导致PMD严重表型的观点。